Crossref


2. Metabolic adaptation via regulated enzyme degradation in the pathogenic yeast Candida albicans

- S.Y. Ting

- O.A. Ishola

- M.A. Ahmed

- Y.M. Tabana

- S. Dahham

- M.T. Agha

- S.F. Musa

- R. Muhammed

- L.T.L. Than

- D. Sandai

6. Resistance of Candida albicans Biofilms to Drugs and the Host Immune System

- Doblin Sandai

- Yasser M Tabana

- Ahmad El Ouweini

- Ishola Oluwaseun Ayodeji

7. Pleurotus sajor‐caju can be used to synthesize silver nanoparticles with antifungal activity against Candida albicans

- Siti Fadhilah Musa

- Ting Seng Yeat

- Laina Zarisa Mohd Kamal

- Yasser M Tabana

- Mowaffaq Adam Ahmed

- Ahmad El Ouweini

- Vuanghao Lim

- Lee Chee Keong

- Doblin Sandai

9. Glyoxylate cycle gene ICL1 is essential for the metabolic flexibility and virulence of Candida glabrata

- Shu Yih Chew

- Kok Lian Ho

- Yoke Kqueen Cheah

- Tzu Shan Ng

- Doblin Sandai

- Alistair J. P. Brown

- Leslie Thian Lung Than

10. Identification of Alkaloid Compounds Arborinine and Graveoline from Ruta angustifolia (L.) Pers for their Antifungal Potential against Isocitrate lyase (ICL1) gene of Candida albicans

- Laina Zarisa Mohd Kamal

- Mowaffaq Adam Ahmed Adam

- Siti Nurfatimah Mohd. Shahpudin

- Ahmad Naqeeb Shuib

- Rosline Sandai

- Norazian Mohd Hassan

- Yasser Tabana

- Dayang Fredalina Basri

- Leslie Thian Lung Than

- Doblin Sandai

11. Setting New Routes for Antifungal Drug Discovery Against Pathogenic Fungi

- Kleber S. Freitas e Silva

- Lívia C. Silva

- Relber A. Gonçales

- Bruno J. Neves

- Célia M.A. Soares

- Maristela Pereira